伏立康唑中间体-2 - Names and Identifiers
Name | (2r,3s|2s,3r)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol
|
Synonyms | N-1STEP Voriconazole Impurity 1 Voriconazole Impurity 12 Voriconazole USP Related Compound A (2RS,3RS)-α-(2,4-Difluorophenyl)-5-fluoro-β-Methyl-α-(1H-1,2,4-triazol-1-ylMethyl)-4-pyriMidineethanol
|
CAS | 182230-43-9
|
EINECS | 605-961-5 |
InChI | InChI=1/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m1/s1 |
伏立康唑中间体-2 - Physico-chemical Properties
Molecular Formula | C16H14F3N5O
|
Molar Mass | 349.31 |
Density | 1.42±0.1 g/cm3(Predicted) |
Melting Point | 123-128°C (dec.) |
Boling Point | 508.6±60.0 °C(Predicted) |
Solubility | Chloroform (Slightly), Methanol (Slightly) |
Appearance | Solid |
Color | White to Off-White |
pKa | 11.54±0.29(Predicted) |
Storage Condition | 2-8°C |
Refractive Index | 1.617 |
伏立康唑中间体-2 - Risk and Safety
伏立康唑中间体-2 - Introduction
Nature:
(2R,3S | 2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1, 2,4-triazol-1-yl)-2-butanol is a chiral compound. It is a solid with a specific molecular structure and spatial configuration. Specific physicochemical properties (such as melting point, boiling point, etc.) may require laboratory testing to determine.
Use:
(2R,3S | 2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1, 2,4-triazol-1-yl)-2-butanol may have some fields of application. According to its structural characteristics, it may be used in drug research and development, organic synthesis, chemical reaction exploration and so on. However, the specific use needs further research and experimental verification.
Method:
(2R,3S | 2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl) the preparation method of -1-(1H-1, 2,4-triazol-1-yl)-2-butanol may require the support of organic synthesis technology. The specific preparation method may depend on factors such as reaction conditions, raw material selection and catalyst.
Safety Information:
Last Update:2024-04-09 20:45:29